Nortriptyline withdrawal

Pro Research Analysisby

Searched over 200M research papers for "nortriptyline withdrawal"

Analyzed relevant papers

Nortriptyline Withdrawal: Insights from Recent Research

Introduction to Nortriptyline Withdrawal

Nortriptyline, a tricyclic antidepressant, is commonly used for treating depression and aiding smoking cessation. However, withdrawal from nortriptyline can present various challenges. This article synthesizes recent research findings on nortriptyline withdrawal, focusing on withdrawal symptoms, management strategies, and comparative studies with other treatments.

Withdrawal Symptoms and Management in Pediatric Patients

A study on children and adolescents aged 6 to 16 years who were gradually tapered off nortriptyline revealed that most did not experience significant withdrawal symptoms. Only a few subjects reported brief gastrointestinal distress, which did not necessitate additional medication . This suggests that a scheduled tapering approach can effectively mitigate withdrawal symptoms in pediatric patients.

Nortriptyline and Smoking Cessation: Withdrawal Symptom Insights

Several studies have explored the use of nortriptyline in smoking cessation programs and its impact on withdrawal symptoms. A randomized controlled trial found that nortriptyline, when combined with nicotine replacement therapy, did not significantly differ from placebo in terms of overall withdrawal symptom scores. However, it did reduce specific symptoms such as depression and anxiety . Another study confirmed that nortriptyline reduced several withdrawal symptoms, including anxiety, irritability, and restlessness, by the eighth day after quitting smoking .

Comparative Efficacy in Rodent Models

Research using rodent models has provided additional insights into the efficacy of nortriptyline in alleviating nicotine withdrawal symptoms. High doses of nortriptyline were found to reduce somatic signs of nicotine withdrawal, such as body shakes and head shakes, to levels comparable to control groups . This supports clinical findings that nortriptyline can alleviate withdrawal symptoms, although the effective doses also suppressed locomotor activity.

Nortriptyline Combined with Other Therapies

Combining nortriptyline with other therapies, such as transdermal nicotine, has been investigated to enhance smoking cessation rates. One study reported that this combination increased cessation rates but had little effect on withdrawal symptoms . This suggests that while nortriptyline can be effective in smoking cessation, its impact on withdrawal symptoms may be limited when used in combination therapies.

Patient Beliefs and Withdrawal Experiences

Patient beliefs about drug assignment can influence their withdrawal experiences. A study assessing the relationship between beliefs about drug assignment and abstinence status found that participants who experienced side effects were more likely to correctly identify their drug as nortriptyline. However, belief about drug assignment did not significantly correlate with abstinence status at follow-up . This indicates that side effects may play a role in patients' perceptions of their treatment, but do not necessarily impact withdrawal outcomes.

Conclusion

Research indicates that nortriptyline withdrawal can be managed effectively with a scheduled tapering approach, particularly in pediatric patients. While nortriptyline is beneficial in reducing specific withdrawal symptoms in smoking cessation programs, its overall impact on withdrawal symptoms may vary depending on the combination of therapies used. Understanding patient perceptions and managing side effects are also crucial in optimizing withdrawal experiences. Further studies are needed to explore the long-term effects of nortriptyline withdrawal and develop comprehensive management strategies.

Sources and full results

Most relevant research papers on this topic

Prospective study of scheduled withdrawal from nortriptyline in children and adolescents.

Scheduled tapering of nortriptyline in children and adolescents can prevent withdrawal symptoms without requiring extra doses.

Non-RCT

1987·

17citations

·B. Geller et al.

Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation: pragmatic randomised controlled trial

Nortriptyline and nicotine replacement therapy are both effective for smoking cessation, but the combination's effect is less than either alone and evidence is lacking for a more effective combination treatment.

RCTLarge Human TrialRigorous Journal

2008·

57citations

·P. Aveyard et al.

Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal

Bupropion and nortriptyline both alleviate somatic signs of nicotine withdrawal in rodents, supporting their clinical efficacy as smoking cessation aids.

Non-RCTAnimal StudyRigorous Journal

2007·

22citations

·V. Wing et al.

A randomized trial of nortriptyline for smoking cessation.

Nortriptyline hydrochloride increases short-term smoking cessation rates and reduces withdrawal symptoms, potentially offering a new therapeutic approach to smoking cessation.

RCTHighly Cited

1998·

189citations

·A. Prochazka et al.

The treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo

L-tryptophan, amitriptyline, and L-tryptophan-amitriptyline combination are more effective than placebo in treating depression in general practice.

RCTHighly Cited

1982·

180citations

·J. Thomson et al.

A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.

Nortriptyline combined with transdermal nicotine increased smoking cessation rates without significantly reducing withdrawal symptoms.

RCT

2005·

38citations

·A. Prochazka et al.

Belief about drug assignment and abstinence in treatment of cigarette smoking using nortriptyline.

Belief about drug assignment in smoking cessation treatment with nortriptyline is not related to abstinence status, but experience during treatment may influence this belief.

RCTLarge Human Trial

2007·

7citations

·S. Hall et al.

Stopping smoking: a prospective, randomized, double-blind study comparing nortriptyline to placebo.

Nortriptyline significantly increases the smoking cessation rate in chronic smokers without significant side effects.

RCT

2002·

65citations

·C. L. da Costa et al.

Inhibition of CYP2D6 with low dose (5 mg) paroxetine in patients with high 10‐hydroxynortriptyline serum levels‐A prospective pharmacokinetic study

5 mg paroxetine addition effectively lowers high hydroxynortriptyline serum levels to safe ranges, enabling therapeutic nortriptyline therapy in 80% of patients.

Non-RCTVery Rigorous Journal

2020·

3citations

·N. Jessurun et al.

Reduced cardio-respiratory coupling after treatment with nortriptyline in contrast to S-citalopram.

Nortriptyline treatment for major depression leads to reduced heart rate variability and cardio-respiratory coupling, potentially increasing cardiovascular risk in patients.

Non-RCTRigorous Journal

2010·

19citations

·K. Bär et al.

Try another search

how much collagen should i take

what vitamins can you not take together

fever and difficulty breathing

is pharyngitis contagious

mental disorder support groups

how much fish oil should i take daily